Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Concordance Evaluation of the T-SPOT®.TB Assay Performance Using Positive Selection With the T-Cell SelectTM Kit and Density Gradient Cell Isolation Methods

NCT04141982 is registered in ClinicalTrials.gov with Oxford Immunotec as lead sponsor.

NCT NCT04141982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Concordance Evaluation of the T-SPOT®.TB Assay Performance Using Positive Selection With the T-Cell SelectTM Kit and Density Gradient Cell Isolation Methods
Lead sponsor
Oxford Immunotec
Phase
Observational
Overall status
Completed
Start date
November 4, 2019
Completion date
March 18, 2020
Enrollment
680 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis